IAI SPECIAL EDITION: Optimal scenario of antihypertension's cost-effectiveness in Prolanis hypertension patients: A case study of Pandeglang District, Indonesia

Authors

  • Yusransyah STIKes Salsabila Serang, Pharmacy Study Program, Banten, Indonesia
  • Eli Halimah Universitas Padjadjaran, West Java, Indonesia
  • Auliya A. Suwantika Universitas Padjadjaran, West Java, Indonesia

DOI:

https://doi.org/10.46542/pe.2022.222.8591

Keywords:

EQ-5D-5L questionnaire, GDP per capita, ICER, Sensitivity analysis

Abstract

Background: Since hypertension prevalence has increased, its economic burden has also increased in all regions, including Pandeglang District in Banten Province, Indonesia. In 2014, the government launched a chronic disease management programme (Prolanis) to optimise hypertension treatment in Primary Healthcare Centres (PHCs) through the Social Health Insurance Administration Body (BPJS Kesehatan). Pharmacists' counseling is important in this as it can increase the effectiveness of hypertension treatment.       

Objective: To investigate the cost-effectiveness of pharmacists’ counselling for Prolanis hypertension patients at PHCs.

Methods: An experimental study was conducted at 16 PHCs using a purposive sampling method. The total sample included 96 Prolanis hypertension patients divided into two groups of 48 participants (an intervention and control group). Incremental cost-effectiveness ratio (ICER) was applied by comparing the cost per quality-adjusted life-year (QALY) gained in both groups. A validated EuroQol-5 Dimension-5 Level (EQ-5D-5L) questionnaire and its Indonesian value set were employed to measure patient quality of life, and the local GDP per capita threshold for cost-effectiveness was used.         

Results: Pharmacists' counseling intervention is cost-effective (ICER: IDR.2,000-28,307 per QALY-gained) within several scenarios with varying fees. Sensitivity analysis showed that the patient's utility score and the pharmacist`s counseling fee were the most influential parameters impacting the ICER.   

Conclusion: Pharmacist`s counselling can be considered as a promising intervention to optimise Prolanis hypertension treatments at PHCs.

Author Biographies

Eli Halimah, Universitas Padjadjaran, West Java, Indonesia

Department of Clinical Pharmacy, Faculty of Pharmacy

Auliya A. Suwantika, Universitas Padjadjaran, West Java, Indonesia

Center of Excellence in Higher Education for Pharmaceutical Care Innovation

References

Adibe, M. O., Aguwa, C. N. & Ukwe, C. V. (2013) Cost-utility analysis of pharmaceutical care intervention versus usual care in management of nigerian patients with type 2 diabetes', Value in Health Regional Issues. https://doi.org/10.1016/j.vhri.2013.06.009

Jerant, A., Franks, P. & Kravitz, R. L. (2011) Associations between pain control self-efficacy, self-efficacy for communicating with physicians, and subsequent pain severity among cancer patients, Patient Education and Counseling. https://doi.org/10.1016/j.pec.2010.11.007

Kemenkes, R.I. (2013) Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. Jakarta:, Laporan Nasional 2013

Kemenkes, R.I. (2018) Hasil Utama Riset Kesehatan Dasar Tahun 2018, Kementrian Kesehatan Republik Indonesia

Korman, M. & Wisløff, T. (2018) Modelling the cost-effectiveness of PCSK9 inhibitors vs ezetimibe through LDL-C reductions in a Norwegian setting, European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvx010

Peraturan BPJS Kesehatan No.2 (2015) Peraturan Badan Penyelenggara Jaminan Sosial Kesehatan Nomor 2 Tahun 2015 tentang norma penetapan besaran kapitasi dan pembayaran kapitasi berbasis pemenuhan komitmen pelayanan pada fasilitas kesehatan tingkat pertama, Animal Genetics

Peraturan Presiden (2015) Peraturan Presiden (Perpres) Nomor 131 Tahun 2015 tentang Penetapan Daerah Tertinggal Tahun 2015-2019. Indonesia

Pérez-Escamilla, B., Franco-Trigo, L., Moullin, J.C., Martinez-Martinez, F., & Garcia-Corpas, J.P. (2015) Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments, Patient Preference and Adherence. https://doi.org/10.2147/PPA.S76139

Yusransyah, Halimah, E, & Suwantika A, A. (2020) Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument, Patient Preference and Adherence, 2020(14), 1103–1109. http://doi.org/10.2147/PPA.S249085

Zhang, L. Guo, X., Zhang, J., Chen, X., Zhou, C., Ge, D., & Qian, Y. (2017) Health-related quality of life among adults with and without hypertension: A population-based survey using EQ-5D in Shandong, China, Scientific Reports. https://doi.org/10.1038/s41598-017-15083-4

Downloads

Published

2022-03-31

How to Cite

Yusransyah, Halimah, E. ., & Suwantika, A. A. . (2022). IAI SPECIAL EDITION: Optimal scenario of antihypertension’s cost-effectiveness in Prolanis hypertension patients: A case study of Pandeglang District, Indonesia. Pharmacy Education, 22(2), p. 85–91. https://doi.org/10.46542/pe.2022.222.8591

Issue

Section

Special Edition